Andy i keep asking myself why i'm still in this stock, pxd triles only half done, if the results come out the same as phase 11 this still dos'nt mean the FDA will give the nod, if nrt is in talks with a partner dose this mean a retrile, do we have to start all over again??????or is NV128 so good that nrt thought why continue to bother with PXD when the real jewel in the crown is NV128 , its got me beat and i still beleive managment need a kick up the pants for not being more clear on there intentions......regards
NRT Price at posting:
46.3¢ Sentiment: None Disclosure: Held
